Phase 1 Study of ACR-2316 in Specific Advanced Solid Tumors

Clinical trial NCT06667141 · RECRUITING

Trial details

NCT number: NCT06667141
Sponsor: Acrivon Therapeutics
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Specific Advanced Solid Tumors

Start date: 2024-10-08
Primary completion: 2026-08-12
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.